Ellevest, Inc. Dexcom Inc Transaction History

Ellevest, Inc.

$608 Million
Q2 2025

A detailed history of Ellevest, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Ellevest, Inc. holds 5,717 shares of DXCM stock, worth $389,899. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,717

Previous 6,094 6.19%

Holding current value

$389,899

Previous $416,000 19.95%

% of portfolio

0.08%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$59.83 - $87.57 $22,555 - $33,013	-377 Reduced 6.19%	5,717 $499,000
Q1 2025 May 14, 2025	BUY	$67.74 - $90.75 $64,623 - $86,575	954 Added 18.56%	6,094 $416,000
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $337,595 - $416,391	5,140 New	5,140 $399,000
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $20,627 - $26,264	-187 Reduced 3.86%	4,663 $528,000
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $27,983 - $34,324	245 Added 5.32%	4,850 $672,000
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $11,625 - $19,120	154 Added 3.46%	4,605 $571,000
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $2,753 - $4,413	32 Added 0.72%	4,451 $415,000
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $84,689 - $98,627	753 Added 20.54%	4,419 $567,000
Q1 2023 May 04, 2023	BUY	$104.0 - $122.92 $17,472 - $20,650	168 Added 4.8%	3,666 $425,000
Q4 2022 Feb 03, 2023	SELL	$84.98 - $122.67 $15,381 - $22,203	-181 Reduced 4.92%	3,498 $396,000
Q3 2022 Nov 02, 2022	SELL	$76.35 - $94.18 $15,728 - $19,401	-206 Reduced 5.3%	3,679 $296,000
Q2 2022 Jul 18, 2022	BUY	$67.99 - $132.89 $192,343 - $375,945	2,829 Added 267.9%	3,885 $290,000
Q1 2022 Apr 19, 2022	BUY	$94.08 - $130.2 $56,448 - $78,120	600 Added 131.58%	1,056 $540,000
Q4 2021 Jan 24, 2022	BUY	$129.87 - $162.82 $57,402 - $71,966	442 Added 3157.14%	456 $245,000
Q3 2021 Oct 19, 2021	SELL	$106.71 - $143.18 $1,280 - $1,718	-12 Reduced 46.15%	14 $8,000
Q2 2021 Jul 13, 2021	SELL	$80.99 - $107.93 $6,398 - $8,526	-79 Reduced 75.24%	26 $11,000
Q4 2020 Feb 04, 2021	SELL	$78.0 - $104.5 $1,638 - $2,194	-21 Reduced 16.67%	105 $39,000
Q3 2020 Oct 26, 2020	BUY	$95.51 - $112.95 $191 - $225	2 Added 1.61%	126 $52,000
Q2 2020 Jul 06, 2020	BUY	$62.68 - $105.34 $62 - $105	1 Added 0.81%	124 $50,000
Q4 2019 Feb 05, 2020	BUY	$36.62 - $57.29 $4,247 - $6,645	116 Added 1657.14%	123 $27,000
Q3 2019 Oct 08, 2019	BUY	$35.53 - $43.8 $71 - $87	2 Added 40.0%	7 $1,000
Q2 2019 Aug 20, 2019	SELL	$27.84 - $38.92 $111 - $155	-4 Reduced 44.44%	5 $1,000
Q4 2018 Jan 25, 2019	BUY	$26.99 - $37.37 $242 - $336	9 New	9 $1,000

Others Institutions Holding DXCM

# of Institutions

1,109

Shares Held

367M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account